UAE Mrna Synthesis Raw Materials Market Size & Outlook
UAE mrna synthesis raw materials market, 2018-2030 (US$M)
Related Markets
UAE mrna synthesis raw materials market highlights
- The UAE mrna synthesis raw materials market generated a revenue of USD 18.4 million in 2023 and is expected to reach USD 19.6 million by 2030.
- The UAE market is expected to grow at a CAGR of 0.9% from 2024 to 2030.
- In terms of segment, capping agents was the largest revenue generating type in 2023.
- Capping Agents is the most lucrative type segment registering the fastest growth during the forecast period.
Mrna synthesis raw materials market data book summary
| Market revenue in 2023 | USD 18.4 million |
| Market revenue in 2030 | USD 19.6 million |
| Growth rate | 0.9% (CAGR from 2023 to 2030) |
| Largest segment | Capping agents |
| Fastest growing segment | Capping Agents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Capping Agents, Nucleotides, Plasmid DNA, Enzymes |
| Key market players worldwide | Roche Holding AG, Merck KGaA, Thermo Fisher Scientific Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, New England Biolabs, Creative-Biolabs, Jena Bioscience, YEASEN Biotechnology, BOC Sciences, Hongene Biotechnology |
Other key industry trends
- In terms of revenue, UAE accounted for 0.6% of the global mrna synthesis raw materials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa mrna synthesis raw materials market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 19.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Synthesis Raw Materials Market Scope
MRNA Synthesis Raw Materials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE mrna synthesis raw materials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna synthesis raw materials market will help companies and investors design strategic landscapes.
Capping agents was the largest segment with a revenue share of 40.76% in 2023. Horizon Databook has segmented the UAE mrna synthesis raw materials market based on capping agents, nucleotides, plasmid dna, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE pharmaceuticals market is rapidly growing. Although UAE currently imports majority of its pharmaceuticals, this scenario is changing, and some international pharmaceutical giants have partnered with UAE companies to manufacture products locally.
The COVID-19 pandemic has increased the country’s focus on investing in life sciences, both domestically and internationally. For instance, in January 2023, National Resilience planned to build first Good Manufacturing Facility in UAE which would manufacture COVID-19 vaccine for Moderna, Inc. and plasma-derived products for Takeda Pharmaceuticals.
Reasons to subscribe to UAE mrna synthesis raw materials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE mrna synthesis raw materials market databook
-
Our clientele includes a mix of mrna synthesis raw materials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE mrna synthesis raw materials market , including forecasts for subscribers. This country databook contains high-level insights into UAE mrna synthesis raw materials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE mrna synthesis raw materials market size, by type, 2018-2030 (US$M)
UAE MRNA Synthesis Raw Materials Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
